MedPath
FDA Approval

FENTANYL CITRATE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Hospira, Inc.
DUNS: 141588017
Effective Date
January 11, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fentanyl(50 ug in 1 mL)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Hospira, Inc.

Hospira, Inc.

827731089

Hospira Worldwide, LLC

Hospira, Inc.

963711309

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FENTANYL CITRATE

Product Details

NDC Product Code
0409-9093
Application Number
NDA019115
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
December 11, 2019
FentanylActive
Code: MUN5LYG46HClass: ACTIMQuantity: 50 ug in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT

FENTANYL CITRATE

Product Details

NDC Product Code
0409-9094
Application Number
NDA019115
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
December 11, 2019
FentanylActive
Code: MUN5LYG46HClass: ACTIMQuantity: 50 ug in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath